Search Within

Yeva Fishinevich

Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. GSK Faculty (5)
  2. Sloan Kettering Institute Postdocs (5)
  3. Tow Center for Developmental Oncology (TCDO) (5)
  4. Department of Pathology and Laboratory Medicine (4)
  5. Alumni (GSK) (3)
  6. Department of Medicine (3)

More Groups

People
  1. Cristina Antonescu (4)
  2. Amish Patel (3)
  3. Cindy Lee (3)
  4. Juan Yan (3)
  5. Miguel Miranda-Roman (3)
  6. Mohini Pachai (3)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (2)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer Discovery (1)
  3. JCO Precision Oncology (1)
  4. Oncogenesis (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (1)
  3. Nature Publishing Group (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-deficient malignant peripheral nerve sheath tumor
    Journal Article

    Miranda-Román, M. A.; Lee, C. J.; Fishinevich, E.; Ran, L.; Patel, A. J.; Yan, J.; Khudoynazarova, M. N.; Warda, S.; Pachai, M. R.; Chen, Y.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Modeling extraordinary response through targeting secondary alterations in fusion-associated sarcoma
    Journal Article

    Vanoli, F.; Song, E.; Dermawan, J. K.; Fishinevich, E.; Sung, P.; Min, S. S.; Xie, Z.; de Traux de Wardin, H.; Hwang, S.; Maki, R. G.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy
    Journal Article

    Vanoli, F.; Herviou, L.; Tsuda, Y.; Sung, P.; Xie, Z.; Fishinevich, E.; Min, S. S.; Mallen, W.; de Traux de Wardin, H.; Zhang, Y.; more...
    Oncogenesis (2023)

    Fulltext@MSK | Save
  • PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor
    Meeting Abstract

    Chi, P.; Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • PRC2-inactivating mutations in cancer enhance cytotoxic response to DNMT1-targeted therapy via enhanced viral mimicry
    Journal Article

    Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; Bayshtok, G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save